Article Sidebar

pdf
Date Published: 14/10/2024
Abstract Views: 71
Views pdf: 67
DOI: https://doi.org/10.51298/vmj.v543i1.11299
Issue
Vol. 543 No. 1 (2024)
Section
Các bài báo
How to Cite
Nguyễn, D. T., Hà, T. H., & Mai, D. T. (2024). CLINICAL SYMPTOMS, IMAGING AND SOME POOR PROGNOSTIC FACTORS IN ACUTE ISCHEMIC STROKE IN INDIVIDUALS WITH DIABETES. Vietnam Medical Journal, 543(1). https://doi.org/10.51298/vmj.v543i1.11299

CLINICAL SYMPTOMS, IMAGING AND SOME POOR PROGNOSTIC FACTORS IN ACUTE ISCHEMIC STROKE IN INDIVIDUALS WITH DIABETES

Duy Toản Nguyễn, Trần Hưng Hà, Duy Tôn Mai

Main Article Content

Abstract

Ischemic stroke in individuals with diabetes ineffective responds to internal medicine and physical medicine and rehabilitation. In addition, those who have diabetes have poorer sequelae than those who do not. Objectives: To evaluate clinical features, imaging and analyze some prognosis factors dismal in the group of ischemic stroke patients with diabetes. Study method: A descriptive cross-sectional study was conducted on 125 ischemic stroke patients with diabetes from May to November 31st 2023 at Bachmai Stroke Center.  Results: in 125 selected samples (males 83 (66.4%)), median age 66 (59-74). After 3 months, 29 patients (23.2%) had poor clinical outcomes (mRS 3-6). Factors associated with poor prognosis include: high NIHSS score ≥ 16 at the time of admission (OR=5.57, 95% CI:3.78-8.21, p<0.01); occlusion or stenosis of intracranial vessels over 50% (OR=8.18, 95%CI: 3.25-20.57, p<0.01); and need to use insulin to control blood sugar (OR=2.39, 95% CI: 0.73-7.81, p<0.05). Conclusions: Those who are suffered from Ischemic stroke in people with diabetes have a dismal clinical outcome than people without diabetes.

Article Details

Keywords

Ischemic stroke, diabete, clinical outcome

References

Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42 (34): 3227-3337. doi:10.1093/eurheartj/ehab484
2. Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci. 2016;351(4):380-386. doi:10.1016/j.amjms.2016.01.011
3. Magliano D, Boyko EJ. IDF Diabetes Atlas. 10th edition. International Diabetes Federation; 2021.
4. Ton MD, Dao PV, Nguyen DT, et al. Sex disparity in stroke outcomes in a multicenter prospective stroke registry in Vietnam. Int J Stroke. Published online June 1, 2023:174749302311778. doi:10.1177/17474930231177893
5. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care. 2005; 28(2):355-359. doi:10.2337/diacare.28.2.355
6. Arboix A, Rivas A, García-Eroles L, de Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: Clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 2005;5(1):9. doi:10.1186/1471-2377-5-9
7. Li A le, Zhu S, Hu Z hao, Peng Q, Fang X, Zhang Y ying. The distribution and epidemic characteristics of cerebrovascular disease in followed-up hypertension patients. Sci Rep. 2021;11:9366. doi:10.1038/s41598-021-88127-5
8. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35-41. doi:10.1161/01.str.24.1.35
9. Sari Aslani P, Rezaeian S, Safari E. 3-Month Outcome of Ischemic Stroke Patients Underwent Thrombolytic Therapy; a Cohort Study. Arch Acad Emerg Med. 2020;8(1):e6.
10. Magalhães R, Abreu P, Correia M, Whiteley W, Silva MC, Sandercock P. Functional status three months after the first ischemic stroke is associated with long-term outcome: data from a community-based cohort. Cerebrovasc Dis Basel Switz. 2014;38(1):46-54. doi:10.1159/000364938